v3.26.1
SCHEDULE OF BUSINESS COMBINATION CONTINGENT CONSIDERATION (Details)
Jun. 30, 2026
USD ($)
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]  
Cash $ 310,000
Receipt of Company shares (41,192)
Total Consideration 268,808
Total Assets of Phytanix 62,103
Less: Total Liabilities of Phytanix 7,641,630
Net Liabilities Deconsolidated (7,579,527)
Less: Net Assets Deconsolidated 7,579,527
Gain on disposal of subsidiary $ (7,310,719)